License-In
Summaries of 2 newly published patent applications are added to "Patent Portfolio"
We released the summaries of 2 newly published patent applications from our "Patent Portfolio" as follows. AJ141 Compound for removing huma...
results 141 - 150 of 231
Other
Updated the “Patent Information”
New patent information relates to iPS cell technologies for the month of February 2018 has been updated. Please see Patent Information for m...
License-Out
License Agreement Has Been Entered with Platelet Biogenesis, Inc.
We executed a non-exclusive license agreement with Platelet Biogenesis, Inc. (Cambridge, U.S.A.) for the use of iPS cell-derived platelet pr...
License-In
License Agreement Has Been Entered with Kwansei Gakuin University
We have executed an exclusive license-in agreement with Kwansei Gakuin University as to their invention under a patent entitled “Method for ...
Other
Updated the “Patent Information”
New patent information relates to iPS cell technologies for the month of January 2018 has been updated. Please see Patent Information for mo...
License-Out
License Agreement Has Been Entered with Stemnovate Ltd.
We executed a non-exclusive license agreement with Stemnovate Ltd. which provides services related to iPS cells for research use, on the pat...
License-In
Summaries of 4 newly published patent applications are added to "Patent Portfolio"
We released the summaries of 4 newly published patent applications from our "Patent Portfolio" as follows. AJ146 Method for producing CD4/C...
License-Out
License Agreement Has Been Entered with Elpis Biomed Limited
We have executed a non-exclusive license agreement with Elpis Biomed Limited, under which Elpis generates iPS cell-derived, differentiated h...
Other
Updated the “Patent Information”
New patent information relates to iPS cell technologies for the month of December 2017 has been updated. Please see Patent Information for m...
License-Out
License Agreement Has Been Entered between iPS Academia Japan, Inc. and myriamed GmbH
iPS Academia Japan, Inc.: We executed a non-exclusive license agreement with myriamed GmbH, Germany which provides services in drug developm...
